Steven A Feldman

Steven A Feldman

UNVERIFIED PROFILE

Are you Steven A Feldman?   Register this Author

Register author
Steven A Feldman

Steven A Feldman

Publications by authors named "Steven A Feldman"

Are you Steven A Feldman?   Register this Author

49Publications

1875Reads

21Profile Views

T Cells Genetically Modified to Express an Anti-B-Cell Maturation Antigen Chimeric Antigen Receptor Cause Remissions of Poor-Prognosis Relapsed Multiple Myeloma.

J Clin Oncol 2018 08 29;36(22):2267-2280. Epub 2018 May 29.

Jennifer N. Brudno, Irina Maric, Steven D. Hartman, Jeremy J. Rose, Norris Lam, Maryalice Stetler-Stevenson, Dalia Salem, Constance Yuan, Steven Pavletic, Jennifer A. Kanakry, Lekha Mikkilineni, Steven A. Feldman, David F. Stroncek, Brenna G. Hansen, Rashmika Patel, Frances Hakim, Ronald E. Gress, and James N. Kochenderfer, National Institutes of Health, Bethesda; Syed Abbas Ali, Johns Hopkins University Sidney Kimmel Comprehensive Cancer Center, Baltimore; Judith Lawrence, Leidos Biomedical Research, Frederick, MD; Michael Wang, University of Texas MD Anderson Cancer Center, Houston, TX; and Dalia Salem, Mansoura University, Mansoura, Egypt.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2018.77.8084
Publisher Site
http://dx.doi.org/10.1200/JCO.2018.77.8084DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6067798PMC
August 2018

Myeloid Conditioning with c-kit-Targeted CAR-T Cells Enables Donor Stem Cell Engraftment.

Mol Ther 2018 05 10;26(5):1181-1197. Epub 2018 Mar 10.

Genetic Immunotherapy Section, Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD 20892, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ymthe.2018.03.003DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5993968PMC
May 2018

Enhanced clinical-scale manufacturing of TCR transduced T-cells using closed culture system modules.

J Transl Med 2018 01 24;16(1):13. Epub 2018 Jan 24.

Center for Cellular Engineering, Department of Transfusion Medicine, Clinical Center, National Institutes of Health, 10 Center Drive, MSC-1184, Building 10, Room 3C720, Bethesda, MD, 20892-1184, USA.

View Article

Download full-text PDF

Source
https://translational-medicine.biomedcentral.com/articles/10
Publisher Site
http://dx.doi.org/10.1186/s12967-018-1384-zDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5784598PMC
January 2018

Treatment of Patients With Metastatic Cancer Using a Major Histocompatibility Complex Class II-Restricted T-Cell Receptor Targeting the Cancer Germline Antigen MAGE-A3.

J Clin Oncol 2017 Oct 15;35(29):3322-3329. Epub 2017 Aug 15.

Yong-Chen Lu, Linda L. Parker, Tangying Lu, Zhili Zheng, Mary Ann Toomey, Donald E. White, Xin Yao, Yong F. Li, Paul F. Robbins, Steven A. Feldman, Christopher A. Klebanoff, Stephanie L. Goff, Richard M. Sherry, Udai S. Kammula, James C. Yang, and Steven A. Rosenberg, National Cancer Institute, Bethesda, MD; Pierre van der Bruggen, Ludwig Institute for Cancer Research; De Duve Institute, Université Catholique de Louvain, Brussels; and Walloon Excellence in Life Sciences and Biotechnology (WELBIO), Wallonia, Belgium; Christopher A. Klebanoff, Memorial Sloan Kettering Cancer Center, Parker Institute for Cancer Immunotherapy, New York, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.74.5463DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5652397PMC
October 2017

Lymphoma Remissions Caused by Anti-CD19 Chimeric Antigen Receptor T Cells Are Associated With High Serum Interleukin-15 Levels.

J Clin Oncol 2017 Jun 14;35(16):1803-1813. Epub 2017 Mar 14.

James N. Kochenderfer, Robert P.T. Somerville, Tangying Lu, Victoria Shi, Stephanie L. Goff, James C. Yang, Richard M. Sherry, Christopher A. Klebanoff, Udai S. Kammula, Constance M. Yuan, Mark J. Roschewski, Steven A. Feldman, Lori McIntyre, Mary Ann Toomey, and Steven A. Rosenberg, National Cancer Institute, National Institutes of Health, Bethesda, MD; Adrian Bot, John Rossi, Allen Xue, Marika Sherman, and Arianne Perez, Kite Pharma, Santa Monica, CA; Tatyana Feldman, John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ; and Jonathan W. Friedberg, University of Rochester School of Medicine, Rochester, NY.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2016.71.3024
Publisher Site
http://dx.doi.org/10.1200/JCO.2016.71.3024DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5455597PMC
June 2017

Isolation and Characterization of an HLA-DPB1*04: 01-restricted MAGE-A3 T-Cell Receptor for Cancer Immunotherapy.

J Immunother 2016 06;39(5):191-201

*Surgery Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD †Cellular Biomedicine Group Inc., Cupertino, CA ‡Ludwig Institute for Cancer Research and WELBIO §De Duve Institute, Université Catholique de Louvain, Brussels, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CJI.0000000000000123DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4947411PMC
June 2016

Allogeneic T Cells That Express an Anti-CD19 Chimeric Antigen Receptor Induce Remissions of B-Cell Malignancies That Progress After Allogeneic Hematopoietic Stem-Cell Transplantation Without Causing Graft-Versus-Host Disease.

J Clin Oncol 2016 Apr 25;34(10):1112-21. Epub 2016 Jan 25.

Jennifer N. Brudno, Robert P.T. Somerville, Victoria Shi, Jeremy J. Rose, David C. Halverson, Daniel H. Fowler, Juan C. Gea-Banacloche, Steven Z. Pavletic, Dennis D. Hickstein, Tangying L. Lu, Steven A. Feldman, Alexander T. Iwamoto, Brenna G. Hansen, Bazetta Blacklock-Schuver, Frances T. Hakim, Steven A. Rosenberg, Ronald E. Gress, and James N. Kochenderfer, National Cancer Institute; Roger Kurlander and Irina Maric, National Institutes of Health, Bethesda; Jennifer S. Wilder, Frederick National Laboratory for Cancer Research, Frederick, MD; and Andre Goy, John Theurer Cancer Center at Hackensack University Medical Center, Hackensack, NJ.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.64.5929DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4872017PMC
April 2016

Adoptive Cell Therapy--Tumor-Infiltrating Lymphocytes, T-Cell Receptors, and Chimeric Antigen Receptors.

Semin Oncol 2015 Aug 12;42(4):626-39. Epub 2015 Jun 12.

Surgery Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.seminoncol.2015.05.005DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6295669PMC
August 2015

Evaluation of γ-retroviral vectors that mediate the inducible expression of IL-12 for clinical application.

J Immunother 2012 Jun;35(5):430-9

Surgery Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CJI.0b013e31825898e8DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3358728PMC
June 2012

Augmented lymphocyte expansion from solid tumors with engineered cells for costimulatory enhancement.

J Immunother 2011 Nov-Dec;34(9):651-61

Surgery Branch, National Cancer Institute, National Institutes of Health, Bethesda 20892-1201, MD, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CJI.0b013e31823284c3DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3196370PMC
February 2012

Development of a genetically-modified novel T-cell receptor for adoptive cell transfer against renal cell carcinoma.

J Immunol Methods 2011 Mar 19;366(1-2):43-51. Epub 2011 Jan 19.

Surgery Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jim.2011.01.002DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3061346PMC
March 2011

Construction and preclinical evaluation of an anti-CD19 chimeric antigen receptor.

J Immunother 2009 Sep;32(7):689-702

Surgery Branch of the National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CJI.0b013e3181ac6138DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2747302PMC
September 2009

Identification of linear heparin-binding peptides derived from human respiratory syncytial virus fusion glycoprotein that inhibit infectivity.

J Virol 2007 Jan 18;81(1):261-71. Epub 2006 Oct 18.

Division of Viral Products, Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, MD 20892, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1128/JVI.01226-06DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1797247PMC
January 2007

Identification of an extracellular domain within the human PiT2 receptor that is required for amphotropic murine leukemia virus binding.

J Virol 2004 Jan;78(2):595-602

Section on Molecular Virology, Laboratory of Cellular and Molecular Regulation, National Institute of Mental Health, Bethesda, Maryland 20892, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC368782PMC
http://dx.doi.org/10.1128/jvi.78.2.595-602.2004DOI Listing
January 2004

The chromogranins: their roles in secretion from neuroendocrine cells and as markers for neuroendocrine neoplasia.

Endocr Pathol 2003 ;14(1):3-23

Section on Molecular Virology, Laboratory of Cellular and Molecular Regulation, National Institutes of Health, Bethesda MD 20892-4090, USA.

View Article

Download full-text PDF

Source
July 2003

Confessions of a managed behavioral health care physician.

Authors:
Steven A Feldman

J Dev Behav Pediatr 2002 Feb;23(1 Suppl):S51-6

View Article

Download full-text PDF

Source
February 2002